Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
IL13Rα2
Description:
IL13Rα2 is the interleukin-13 receptor alpha 2 protein, a receptor that binds IL-13 and is studied in immune signaling and cancer biology.
Primary topic:
CAR-T cell therapy research (29%)
Related topics:
CAR-T cell therapy research (29%),
Glioma Diagnosis and Treatment (23%),
Cytokine Signaling Pathways and Interactions (9%)
OpenAlex ID:
keywords/il13ralpha2
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
2016
·
Christine E. Brown
, Darya Alizadeh
, et al.
·
New England Journal of Medicine
·
1,982
PDF
IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis
2005
·
Stefan Fichtner-Feigl
, Warren Strober
, et al.
·
Nature Medicine
·
1,017
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
2015
·
Christine E. Brown
, Behnam Badie
, et al.
·
Clinical Cancer Research
·
837
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
2016
·
Meenakshi Hegde
, Malini Mukherjee
, et al.
·
Journal of Clinical Investigation
·
741
PDF
IL-13 receptors and signaling pathways: An evolving web
2003
·
Gurjit K.Khurana Hershey
·
Journal of Allergy and Clinical Immunology
·
667
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
2017
·
Kevin Bielamowicz
, Kristen Fousek
, et al.
·
Neuro-Oncology
·
455
Immunopathogenesis of human schistosomiasis
2009
·
M. L. BURKE
, M. K. JONES
, et al.
·
Parasite Immunology
·
448
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results
2024
·
Stephen J. Bagley
, Meghan Logun
, et al.
·
Nature Medicine
·
447
Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial
2024
·
Christine E. Brown
, Jonathan C. Hibbard
, et al.
·
Nature Medicine
·
428
PDF
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
2012
·
Surasak Phuphanich
, Christopher J. Wheeler
, et al.
·
Cancer Immunology Immunotherapy
·
407
PDF
Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in Glioblastoma
2013
·
Meenakshi Hegde
, Amanda Corder
, et al.
·
Molecular Therapy
·
392
PDF
Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants
2017
·
Giedre Krenciute
, Brooke L. Prinzing
, et al.
·
Cancer Immunology Research
·
346
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
2019
·
Patrick Y. Wen
, David A. Reardon
, et al.
·
Clinical Cancer Research
·
308
Stem-like Tumor-Initiating Cells Isolated from IL13Rα2 Expressing Gliomas Are Targeted and Killed by IL13-Zetakine–Redirected T Cells
2012
·
Christine E. Brown
, Renate Starr
, et al.
·
Clinical Cancer Research
·
240
Induction of IL-13 Triggers TGF-β1-Dependent Tissue Fibrosis in Chronic 2,4,6-Trinitrobenzene Sulfonic Acid Colitis
2007
·
Stefan Fichtner-Feigl
, Ivan J Fuss
, et al.
·
The Journal of Immunology
·
228
Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2
2016
·
B. Popovic
, J. Breed
, et al.
·
Journal of Molecular Biology
·
210
PDF
IFNγ Is Critical for CAR T Cell–Mediated Myeloid Activation and Induction of Endogenous Immunity
2021
·
Darya Alizadeh
, Robyn A. Wong
, et al.
·
Cancer Discovery
·
197
PDF
Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas
2018
·
Yibo Yin
, Alina C. Boesteanu
, et al.
·
Molecular Therapy — Oncolytics
·
194
Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis
2013
·
Christine E. Brown
, Charles D. Warden
, et al.
·
PLoS ONE
·
182
PDF
Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy
2014
·
B. Thaci
, C. E. Brown
, et al.
·
Neuro-Oncology
·
180
Matrix Metalloproteinase 12-Deficiency Augments Extracellular Matrix Degrading Metalloproteinases and Attenuates IL-13–Dependent Fibrosis
2010
·
Satish K Madala
, John T Pesce
, et al.
·
The Journal of Immunology
·
174
PDF
PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with 89 Zr-Oxine
2018
·
Michael R. Weist
, Renate Starr
, et al.
·
Journal of Nuclear Medicine
·
172
PDF
Off-the-shelf, steroid-resistant, IL13Rα2-specific CAR T cells for treatment of glioblastoma
2022
·
Christine E Brown
, Analiz Rodriguez
, et al.
·
Neuro-Oncology
·
166
Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma
2017
·
Lei Wu
, Wei-Wei Deng
, et al.
·
Cancer Immunology Immunotherapy
·
165
Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Rα2, gp100 and TRP-2 for immunotherapy
2006
·
Stéphan Saikali
, Tony Avril
, et al.
·
Journal of Neuro-Oncology
·
162
Show more works
View as search
Works count:
702
Citation count:
21,460
Year
Topic
Type